Non-Fiction Books:

U.S. Cancer Report

December 2015: The newest anticancer treatments for cancer patient
Click to share your rating 0 ratings (0.0/5.0 average) Thanks for your vote!

By:

Format:

Paperback / softback
$268.00
Available from supplier

The item is brand new and in-stock with one of our preferred suppliers. The item will ship from a Mighty Ape warehouse within the timeframe shown.

Usually ships in 3-4 weeks
Free Delivery with Primate
Join Now

Free 14 day free trial, cancel anytime.

Buy Now, Pay Later with:

4 payments of $67.00 with Afterpay Learn more

6 weekly interest-free payments of $44.67 with Laybuy Learn more

Availability

Delivering to:

Estimated arrival:

  • Around 13-25 June using International Courier

Description

Paradigm of anticancer treatments is shifting rapidly. Cutting-edge anticancer treatment methods are appearing, such as cancer immunotherapy drugs, genome editing, a patient's own stem cell culture treatment and personalized treatment utilizing Big Data of supercomputers. U.S. CANCER REPORT speedily delivers the newest anticancer treatment methods related to cancer every month with a focus on the medical arena in the U.S., which is the nation with the most advanced anticancer treatments. CONTENTS Chapter 1. The Newest Cancer Treatments 1.1. Anticancer Immunotherapy 1.1.1. Immuno-Oncology Therapy: New Hope for Treating Cancer 1.1.2. Cancer Immunotherapy that Can Treat 30 Types of Cancer to Appear 1.1.3. Cancer Immunotherapy Drugs Accelerating Conquest of Cancer 1.1.4. Cancer Experts Demands Reduction in Cost of Cancer Drugs 1.1.5. Cancer Therapy Utilizing Immune Cells 1.2. Cancer Treatments Through Genome Editing 1.2.1. Treating Cancer and Incurable Diseases with Molecular Scissors 1.2.2. Successful Treatment of Leukemia Through Genome Editing 1.2.3. Gene Editing Paves Way for Pig Organ Transplant 1.2.4. Bill Gates-Google Investing in Gene Editing Startup 1.3. Cancer Treatments Using Supercomputer 1.3.1. Supercomputer Diagnosing Patients, Huge Shift in Medical Paradigm Beginning 1.3.2. Google-Apple-IBM Recruiting Streams of Medical Superstars 1.3.3. Google: Focusing on Biotech Projects like Conquering Cancer 1.3.4. Apple: To Utilize iPhone as Tool for Medical Research 1.3.5. Enlitic: To Diagnose and Treat Cancer with Deep Learning Technology 1.4. Other Cancer Treatments 1.4.1. Viral Anticancer Therapy to Destroy Cancer Cells 1.4.2. University of Tokyo in Japan: Reduces Tumor Size to 1/10 with iPS Cells 1.4.3. Cancer Progression-Treatment Effectiveness Trackable with Blood Test 1.4.4. Development of Blood Test to Detect Cancer: 96% Accuracy Rate 1.4.5. BioGemex: Develops Kit That Detects Cancer Early with a Single Drop of Blood within 20 Minutes 1.4.6. Rate at which Cancer Spreads May Increase if Cancer Patients Take Antioxidant Supplements 1.4.7. Aspirin: May Lower Cancer Occurrence and Prevent Cancer Metastasis, but Must be Careful of Side Effects 1.4.8. Large-Scale Clinical Trial into Aspirin's Cancer Suppression Effects to Begin 1.4.9. Cancer Survivors Have Worse Eating Habits than Regular People 1.4.10. Mediterranean Diet: Lowers Death Rate by 20% in Cancer Patients 1.4.11. The National Cancer Institute: Prolonged TV Viewing Increase Death Risk 1.4.12. New Type of Cancer Caused by Parasites Discovered Chapter 2. Disease-specific Cancer Treatments 2.1. Lung Cancer 2.1.1. Cancer Immunotherapy Drugs Giving Hope for Treatment of Lung Cancer 2.1.2. FDA: Approval of 'Keytruda' as Lung Cancer Treatment Drug 2.1.3.MSD Keytruda, Extends Survival of Lung Cancer Patients 2.1.4. FDA Approves Use of BMS's Opdivo in Non-Squamous Non-Small Cell Lung Cancer 2.1.5. Roche's Lung Cancer Drug Tarceva: Effectiveness-Safety Re-Verified 2.1.6. Zykadia, the Lung Cancer Treatment Drug from Novartis, Proven to be Effective in Improving Patient's Quality of Life 2.1.7. Amgen-Allergan's Avastin Biosimilar, Effective in Lung Cancer 2.1.8.Boehringer Ingelheim Conducts Global Phase II Trial on New Targeted Therapy for Lung Cancer 2.1.9. AstraZeneca: Halts Lung Cancer Drug Combination Trials 2.1.10. AstraZeneca's NSCLC Drug TAGRISSO Receives FDA Approval 2.1.11. Why Non-Smokers Contract Lung Cancer 2.1.12. 10 Warning Signs of Lung Cancer That Are Easy to Miss 2.1.13. U.S. Montgomery County: Informing Radon Levels, Cause of Lung Cancer, Compulsory 2.2. Liver Cancer 2.3. Colorectal Cancer 2.4. Prostate Cancer 2.5. Breast Cancer 2.6. Skin Cancer 2.7. Blood Cancer 2.8. Thyroid Cancer 2.9. Pancreatic Cancer 2.10. Kidney Cancer 2.11. Rare Cancer
Release date NZ
November 27th, 2015
Author
Audience
  • General (US: Trade)
Pages
164
Dimensions
216x279x11
ISBN-13
9781519564870
Product ID
37620956

Customer reviews

Nobody has reviewed this product yet. You could be the first!

Write a Review

Marketplace listings

There are no Marketplace listings available for this product currently.
Already own it? Create a free listing and pay just 9% commission when it sells!

Sell Yours Here

Help & options

Filed under...